Navigation Links
New Patent for Adipose Stem Cells Issued to VetStem
Date:9/12/2017

VetStem Biopharma, Inc., announced that a major new European patent has been granted to the University of Pittsburgh and VetStem has full license to that patent. This patent covers methods for isolating stem cells from adipose tissue, the composition of the adipose-derived stem cell itself, combining this stem cell with matrix materials, and incorporating the stem cells in an implant. This patent will provide coverage for the on-going commercial and development programs at VetStem and may be available for licensing to other companies interested in working in this field.

This new patent adds to the other patents in the VetStem portfolio that cover methods of using regenerative cells from adipose tissue for the eye, pancreas, liver, bone and muscle. VetStem has exclusive worldwide rights for veterinary use of these other licensed patents and this strengthens further the company’s intellectual property position in this rapidly developing field.

As the first company in the United States to offer fat derived stem cell services for veterinary use, VetStem has rapidly developed the market, providing treatments to over 13,000 horses, dogs, cats and exotic species. “Intellectual property rights are critical and can be confusing in a rapidly developing market with evolving technology.” said Bob Harman, DVM, MPVM, CEO of VetStem. “We have taken appropriate actions to protect the market that we are creating in regenerative veterinary medicine and to ensure that the value of the company is optimized. The value of this technology has increased greatly since the founding of the company in 2002 as the business model has evolved and many companies and Universities worldwide have validated the therapeutic activity of these cells.”

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 13,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The Company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14629540.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. First-To-File Patent Law Is Now In Effect, But What Does it Mean?
2. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
3. Synedgen Announces Issuance of Patent to Optimize Animal Health
4. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
5. Nutra Pharma Patent and Trademarks Published in India
6. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
7. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
8. LamdaGen Corporation Announces Japan Patent Issuance for Enzymatic Diagnostic Assays on Plasmonic Nano-Sensors
9. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
10. DuPont Receives ‘Patents for Humanity’ Award for Groundbreaking Research to Improve Nutritional Profile of Staple Crop
11. Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... KITCHENER, Canada (PRWEB) , ... August 08, 2018 , ... ... global leader in biotechnology and with a team nearly double its’ size from last ... The sleek new OpenSPR turned heads and impressed crowds at a private ...
(Date:8/7/2018)... , ... August 06, 2018 , ... ... and diagnostics companies, announces the placement of Dr. Paul Harney as President, North ... North America growth strategy and enhancing client satisfaction. He was also named to ...
(Date:7/31/2018)... ... 2018 , ... ZeptoMetrix™ Corporation (ZMC) announced today ... CE/IVD product inventory. , “We are pleased today to introduce two Group B ... committed to fully support and provide our diagnostics industry with as many precise ...
(Date:7/25/2018)... ... 2018 , ... Eileen Meagher, an evidence-based energy healer, announces ... nutraceutical to improve skin health parameters including anti-wrinkling, skin hydration, elasticity and firmness. ... following results:,     More than 500% increase in cell growth ...
Breaking Biology Technology:
(Date:8/2/2018)... ... August 02, 2018 , ... RxS LLC ... biotech companies, today announced that Mark Jara, principal of the organization, has been ... life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive the ...
(Date:8/1/2018)... ... August 01, 2018 , ... Clinical Training ... MA's and Administrative staff. , This full day course is an interactive day ... will expose your staff to regenerative medicine procedures and processing techniques, and facility ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... “Will” Muzek as Business Development Manager. In this role, Mr. Muzek will lead ... accelerate Lifecycle’s continued growth and expansion. , With over 20 years in ...
Breaking Biology News(10 mins):